基于因子聚类分析的中药产业上市公司竞争力实证研究

中药产业是我国具有较大优势的新兴战略产业，提高中药企业竞争力是实现中药现代化的必然选择。基于因子分析和聚类分析方法，运用2012 年42 家中药上市公司的样本数据进行竞争力的测度和分析。研究结果表明，中药企业竞争力主要受经营规模、盈利效率和业绩增长3 方面因素的影响，并且中药企业规模小，竞争力差距大。结合各企业的优劣势，提出相应的发展建议，以提升中药企业竞争力。

An Empirical Study on Competiveness of Chinese Medicine Industry Listed Companies Based on Factor and Cluster Analysis

Chinese medicine industry is the new strategic industry with comparative advantage in China. To achieve modernization of Chinese medicine, improving the competitiveness of Chinese medicine enterprise is an inevitable choice. Based on the method of factor analysis and cluster analysis, this article measured and analyzed the competitiveness of 42 Chinese medicine listed companies by using the data of year 2012. The result showed that the competitiveness of Chinese medicine enterprises was mainly affected by three factors, which were scale of operation,profitability efficiency and growth. The scale of Chinese medicine is small and the large gap of competitiveness exits. To enhance the competiveness of Chinese medicine enterprises, this paper put forward corresponding development recommendations combined with the advantages and disadvantages of Chinese medicine enterprises